These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37263709)

  • 21. lncRNA SSTR5-AS1 Predicts Poor Prognosis and Contributes to the Progression of Esophageal Cancer.
    Hu Y; Mao N; Zheng W; Hong B; Deng X
    Dis Markers; 2023; 2023():5025868. PubMed ID: 36726845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the Role of Necroptosis-Related Long Non-coding RNAs in Hepatocellular Carcinoma: A Necroptosis-Related lncRNA-Based Signature to Predict the Prognosis of Hepatocellular Carcinoma.
    Ye GQ; Wang MD; Diao YK; Li C; Yao LQ; Gu LH; Xu JH; Yang T; Tong XM
    Appl Biochem Biotechnol; 2024 Aug; ():. PubMed ID: 39115788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel histone acetylation-related lncRNA signature for predicting prognosis and tumor microenvironment in esophageal carcinoma.
    Han B; Ma Y; Yang P; Zhao F; Zhu H; Li S; Yu R; Bao S
    Aging (Albany NY); 2024 Mar; 16(6):5163-5183. PubMed ID: 38478744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.
    Zhang C; Lian H; Xie L; Yin N; Cui Y
    Biol Chem; 2020 Aug; 401(9):1053-1061. PubMed ID: 32229685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma.
    Zhang Y; Zhuang T; Xin Z; Sun C; Li D; Ma N; Wang X; Wang X
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer.
    Chen Y; Zhou H; Wang Z; Huang Z; Wang J; Zheng M; Ni X; Liu L
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33960364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel necroptosis-related long non-coding RNA signature predicts prognosis and immune response in cervical cancer patients.
    Kong X; Xiong Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):12947-12964. PubMed ID: 37466792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma.
    Zhao L; Luo H; Dong X; Zeng Z; Zhang J; Yi Y; Lin C
    Medicine (Baltimore); 2022 Sep; 101(39):e30621. PubMed ID: 36181033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
    Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
    Front Immunol; 2022; 13():950365. PubMed ID: 36159855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
    Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
    Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma.
    Liu J; Wang Y; Chu Y; Xu R; Zhang D; Wang X
    Front Cell Dev Biol; 2020; 8():649. PubMed ID: 32850794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
    Zeng C; Yu H; Liu X; Liu Q; Jin J
    Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
    Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
    Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
    Yu-Jing T; Wen-Jing T; Biao T
    Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
    Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
    Wu K; Zhang C; Zhang C; Dai D
    Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
    Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
    Front Genet; 2022; 13():984696. PubMed ID: 36092933
    [No Abstract]   [Full Text] [Related]  

  • 39. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data.
    Li D; Deng W; Huang G; Xiao X
    Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas.
    Ding H; Xu JC; Ding ZG; Wu LF; Liu YB; Zhang YF; Chen TY; Zhang YQ; Zhou PH
    Front Immunol; 2024; 15():1295305. PubMed ID: 38481990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.